Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.
- DOI
- 10.1038/s41467-026-68716-6
- Published
- 2026 Jan 29
- Container
- Nature communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-026-68716-6,
title = {Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.},
author = {Jones RL and Groisberg R and Blay JY and Colman H and De La Fuente M and Roxburgh P and Chao MM and Tian H and Duffaud F and Bahleda R and Van Tine BA},
year = {2026},
journal = {Nature communications},
doi = {10.1038/s41467-026-68716-6},
url = {https://doi.org/10.1038/s41467-026-68716-6}
}RIS
TY - JOUR TI - Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial. AU - Jones RL AU - Groisberg R AU - Blay JY AU - Colman H AU - De La Fuente M AU - Roxburgh P AU - Chao MM AU - Tian H AU - Duffaud F AU - Bahleda R AU - Van Tine BA PY - 2026 JO - Nature communications DO - 10.1038/s41467-026-68716-6 UR - https://doi.org/10.1038/s41467-026-68716-6 ER -
APA
RL, J., R, G., JY, B., H, C., M, D. L. F., P, R., MM, C., H, T., F, D., R, B., & BA, V. T. (2026). Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.. Nature communications. https://doi.org/10.1038/s41467-026-68716-6
Source records
- pubmed · retrieved 2026-09-26T05:14:31.002Z